Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Originally developed at Monash University as part of research into the lipolytic domain of hGH, AOD-9604 retains many of the fat-mobilising characteristics of full-length growth hormone while lacking the broader growth-promoting and insulin-resistance effects associated with the parent molecule
Higher copper loads increase the chance of stinging, dryness, transient tint on the skin, and interaction problems when layered with acids
Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment
Regulatory note: Both BPC-157 and TB-500 are not FDA-approved for human use, and TB-500 is prohibited by WADA (class S2) for athletes
US$ 21.70
US$ 25.94
US$ 28.68
US$ 29.40
US$ 24.96
US$ 26.23
US$ 22.32
US$ 23.21
US$ 23.79
US$ 27.83
